Program
Full ASM Program
Thank you to all our speakers who contributed to this year’s program.
The downloadable conference program has more detailed programming including session chairs.
Click on the button below to download the conference program (PDF)
Theranostics Pre-Conference Symposium | Fitzroy Room |
||
| Start | End | Session / Details |
| 7:30am | 8:30am | Registration and Arrival Tea & Coffee |
| 8:30am | 9:30am | Theranostics Landscape with Welcome from Prof Karen Jones (President, ANZSNM) |
| Australia – Prof Sze Ting Lee | ||
| New Zealand – Dr Rachelle Steyn | ||
| North America – Prof Jean-Luc Urbain | ||
| Global – Prof Andrew Scott | ||
| 9:30am | 10:00am | Prostate Cancer – Prof David Pattison |
| The PRIMARY Journey – Dr James Buteau | ||
| 10:00am | 10:30am | MORNING TEA |
| 10:30am | 11:30am | Updates In Thyroid Cancer – Prof Sze Ting Lee |
| 2025 ATA Thyroid Cancer Guideline Update – Prof David Pattison | ||
| I-124 PET Dosimetry – Dr Matthew Griffiths | ||
| 11:30am | 12:25pm | Practical Overview Of 177Lu-DOTATATE PRRT – Newly Approved In Australia |
| Beware of High risk Patients – Dr Javad Saghebi | ||
| PRRT Treatment – Technologist perspective – Ms Leah Neeson | ||
| Indications and who to treat in the Australian Setting – A/Prof Gabby Cehic | ||
| 12:25pm | 12:30pm | Closing by Prof Karen Jones (President, ANZSNM) |
| 12:30pm | Pre-Conference Symposium Close | |
Annual Scientific Meeting Day 1 |
||||||
| Start | End | Session / Details | ||||
| 1:30pm | 1:45pm | Official Welcome and Opening | Welcome to Country | Royal Theatre | ||||
| 1:45pm | 3:15pm | Opening Plenary – Cardiology | Royal Theatre | ||||
| Coronary Flow Reserve/Microvascular disease – Dr Sam Wright | ||||||
| Cardiac amyloidosis – latest developments – Dr Raef Boktor | ||||||
| Updates in Medicare guidelines – How we got here – Mr Michael Ryan | ||||||
| 3:15pm | 3:45pm | AFTERNOON TEA | ||||
| 3:45pm |
5:00pm |
CME Session – Cardiology: Read with the Experts |
Oncology |
TSIG Session including Radpharm | AANMS Trainee Interest Group (TIG) Forum | |
| Royal Theatre | Swan Room | Fitzroy Room | Torrens Room | |||
| Art of stress testing and protocol selection in 2026 Sam Wright |
FET-PET in Glioblastoma (FIG) Study (TROG 18.06): FET-PET-Guided Target Volume Delineation in Glioblastoma Andrew Scott |
Welcome by the TSIG Chair |
TIG Achievements and Future Directions Karan Singh, Rueben Ganeshalingam |
|||
|
Cases that teach: contemporary cases with emerging clinicians
Moderated by: Barry Elison and Sam Wright |
Same-day dual-radiopharmaceutical paediatric total-body PET/CT imaging Kevin London |
Radpharm VIC/TAS Finalist: Beyond perfusion: coronary flow reserve and the impaired microvascular circulation Eloise Penno |
VQ Scans in CTEPH Shahroz Khan |
|||
| Multimodality cardiac cases Sam Wright |
Vertex to Toes – The clinical necessity of true whole-body PET/MR in paediatric and AYA oncology Brooke King |
Radpharm WA Finalist: Ex gonna give it to ya: GLP, PET/CT and lizard monsters Taylor Hope |
Theranostics for Trainees Sarennya Pathmanandavel |
|||
Session sponsored by: |
Radpharm NSW/ACT Finalist: PSMA and a Vascular Surprise Sasha Aurisch |
Training/Education updates Jen Brown |
||||
| Radpharm SA/NT Finalist: Go With the Flow: Nuclear Medicine Peritoneal Scintigraphy for the evaluation of fluid leak in a paediatric patient. Kimberly Nguyen |
||||||
| Radpharm QLD Finalist: 100%Sensitivity 100%Specificity Richard Boytar |
||||||
| Radpharm RURAL/REGIONAL Finalist: Physiological absence of Gallium PSMA Mitchell Thomson |
||||||
| 5:00pm | 7:00pm | Welcome Reception | Exhibition Hall | Sponsored by: |
|||
| 7:00pm |
AANMS Fellows’ Dinner | Registration through AANMS | |||||
| President’s Dinner | By invitation only | ||||||
Annual Scientific Meeting Day 2 |
||||||
| Start | End | Session / Details | ||||
| 7:00am | 8:00am | Bruker Fun Run/Walk | NCCC – Glebe Park Entrance (6:45am) |
Sponsored by:
|
|||
| 7:15am | 8:15am | Telix Breakfast Session | Fitzroy Room |
Sponsored by:
|
|||
| 8:30am | 10:00am | Plenary: Neurology | Royal Theatre | ||||
| Reading Brain FDG PET – A refresher – Dr Stanley Ngai | ||||||
| Clinical quantification programs for Brain FDG and Amyloid PETR – Dr Tahleesa Cuda | ||||||
| FDG Brain PET is the best test for LATE: What is it and what does the PET look like – Dr Azadeh Feizpour | ||||||
| The expected impact of blood tests for Alzheimer’s disease on PET – it’s both good and bad – Prof Christopher Rowe | ||||||
| 10:00am | 10:30am | Lowenthal Lecture: Quantitative PET as a Catalyst for Precision Oncology – Prof Michael Hofman | Royal Theatre | ||||
| 10:30am | 11:00am | MORNING TEA | ||||
| 11:00am |
12:30pm |
TSIG Session including Landauer and Paul Orr Awards |
AANMS Presentations including Registrar Award |
RPS Session including Shimadzu Award |
Physics | |
| Royal Theatre | Swan Room/Torrens Room | Murray Room | Bradman Theatre | |||
| International speaker: Julie Bolin, MS, CNMT, FSNMMI-TS |
AANMS CME Presentations | Imaging PDL1 with Zirconium-89 Desferrioxamine B Squaramide: From Bench to Bedside Stacey Rudd |
New Geometry Czt Multi-Detector Spect/Ct: Operational And Technical Aspects Dale Bailey |
|||
|
Landauer Award Finalist:
The Role of Radiogenomics in Precision Radiopharmaceutical Therapy: A Lu-177 PSMA Perspective
Franklin Eze
|
Utility of Ga-68 DOTATATE (Gallium-68) in suspected carcinoid heart disease. Dominic Ku |
Shimadzu Award Finalist:
Conjugation and radiolabelling of anti-EphA3 antibody [225Ac]Ac-macropa-tzPEG3Sq-chIIIA4 and preclinical evaluation in a murine glioblastoma model
Christian Wichmann
|
Accuracy of dose calibrator measurements for varying I-123 source geometries Juniper Bedwell-Wilson |
|||
|
Landauer Award Finalist:
The Role of ¹⁸F-FDG PET/CT in the Clinical Assessment of Sarcoidosis: A Retrospective, Single-Centre Review
Jade Pearson-McKenzie
|
AANMS Registrar Award Finalist:
Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Oligodiscordant Gastroenteropancreatic Neuroendocrine Tumours (NETs) – Outcomes from a Quaternary Neuroendocrine Referral Centre in NSW
Claire Mok
|
Shimadzu Award Finalist:
PET imaging of 89Zr-Df-ifabotuzumab-pyrrolobenzodiazepine to evaluate biodistribution in an intracranial tumour model
Ingrid Burvenich
|
A 5-Year Longitudinal Review of Radiation Safety Management Protocols and Occupational Radiation Exposures amidst an Evolving Theranostic Landscape Sylvia Gong |
|||
|
Landauer Award Finalist:
Optimising myocardial perfusion imaging on a GE 870CZT SPECT-CT through utilisation of qualitative and quantitative image-quality metrics.
Annah Skillen
|
AANMS Registrar Award Finalist:
Significance of white adipose tissue FDG uptake on PET/CT: A case report and review of literature
Louisa Thong
|
Shimadzu Award Finalist:
EphA3-targeted radioimmunotherapy for cancer treatment via tumour stroma and tumour cell targeting
Zhipeng Cao
|
PET imaging of cyclotron components provides valuable information on beam interaction and relative activity assessment assisting with disposal of radioactive materials. Matthew Griffiths |
|||
| Uncovering the Unseen: PET-CT Detection of Occult Metastatic Lung Cancer in a Rural Patient with Isolated Hip Pain Jennifer Walter |
AANMS Registrar Award Finalist:
Correlation Between Pre-operative Myocardial Perfusion Imaging And Post-operative Cardiac Events – A Contemporary Assessment From A Large Australian Tertiary Hospital.
Julian Gin
|
Shimadzu Award Finalist:
Establishing Robust Automated Production of [18F]mFBG Using the Trasis AllInOne Synthesiser: A Milestone for Australian Radiopharmacy
Kenneth Hong
|
Evaluating phantom suitability for reliable calculation of detectability index in PET Deborah Carrick |
|||
| Paul Orr Award Presentation: Breaking from cold to very hot, is not so bad. Prue Lamerton |
Session sponsored by: |
Shimadzu Award Finalist:
Optimisation in the Face of Limitations: Improving Solid Target Cu-64 Production Yields
Harris Panopoulos
|
Data-Driven Motion Correction in Amyloid PET for Alzheimer’s Disease: Effects on Centiloid Scores and Image Quality Heidi Espedal |
|||
Session sponsored by: |
|
Session sponsored by: |
||||
| 12:30pm |
1:30pm |
LUNCH | ||||
| AANMS AGM | Fitzroy Room | ||||||
| 1:00pm | 1:30pm | POSTER DEFENCE | GMS AWARD | ||||
| 1:30pm |
3:30pm |
ARTnet Session | Theranostics / Radiopharmaceutical Therapy | Endocrinology and Free Papers |
TSIG Session
including RAPHAEL and Sumitomo Awards
|
|
| Royal Theatre | Swan Room/Torrens Room | Murray Room | Bradman Theatre | |||
|
Overview of ARTnet activities
Roslyn Francis &
Kathy Willowson |
Efficacy and safety of retreatment PRRT – a multicentre Australian study Dale Bailey |
Unmasking the Etiology of PTH independent hypercalcemia on [18 F]FDG PET/CT : A Tertiary Centre Perspective
Nishikant Damle
|
International speaker:
Dr Shannon Youngblood, Ed.D, MSRS, CNMT, R.T.(CT)(ARRT)
|
|||
|
Multicentre clinical trials – update
Andrew Scott, David Pattison, Ivan Ho Shon, Roslyn Francis, Sze Ting Lee
– Prostate trials update
– FIG Study: Andrew Scott
– I-FIRST Study: Andrew Scott & David Pattison
– SNAP Study: Andrew Scott
– ALLG Clinical Trials Update: Ivan Ho Shon & Sze Ting Lee
|
A Small Case Series of Peptide Receptor Radionuclide Therapy in Meningiomas. Rahul Solanki |
Implementation of the first Gallium-68 Exendin-4 PET/CT service in NSW for the evaluation of hypoglycaemic disorders: challenges, lessons and future directions. Jeremy Hoang |
RAPHAEL Award Finalist:
An audit of 18F-FDG PET timings to Lung MDT in non-metastatic lung cancer patients at a tertiary centre
Philip Macilwraith
|
|||
| [18F]FDG (FDG) PET/CT biomarkers are prognostic in Gastroenteropancreatic (GEP) Neuroendocrine Neoplasms (NEN) pre and post Peptide Receptor Radionuclide Therapy (PRRT) Grace Kong (presented by Dale Bailey) |
Evaluating the Clinical Significance of the Pyramidal Lobe on Technetium-99m Thyroid Scans in Graves’ Disease Jack Buchanan |
Sumitomo Award Finalist:
Comparison of planar vs tomographic LVEF in cardiac gated blood pool scans
Hafsah Chao
|
||||
| Clinical utility of CAIX-targeted and PSMA PET/CT imaging in restaging of clear cell renal cell carcinoma Christian Testa |
Splenunculus Mimicking Neuroendocrine Tumour on Ga-68 DOTATATE PET: The Diagnostic Value of Heat-Damaged Red Blood Cell Scintigraphy Winsome Chan |
Sumitomo Award Finalist:
Assessing Treatment Efficacy in ER-Positive Breast Cancer: A PET F-18 FES Case Study
Sarah Pham
|
||||
|
FNIH PDIB global dosimetry project
Dale Bailey
|
Early Prediction of Treatment Response in Neuroendocrine Tumours Using Quantitative PRRT SPECT/CT Jisu Han |
Role of MAG-3 Renography in Bilateral Non-obstructed Primary Megaureters |
Sumitomo Award Finalist:
Who Is Ewing and What Is His Sarcoma?
Kenneth Pan
|
|||
|
New Initiatives
Roslyn Francis & Andrew Scott
|
Estimation of Lesion and Organ retention Of 177Lu- PSMA 617 in Patients with Recurrent Glioblastoma (GBM) Apoorva Tyagi |
Sumitomo Award Finalist:
Compassion satisfaction in nuclear medicine technologists working in Australia and New Zealand
Mikayla Castle
|
||||
|
ARTnet executive update
Kevin London
|
Evaluating efficacy and safety of 68Ga-PSMA-11 PET/CT for detecting biochemical recurrence of prostate cancer in Japanese men Amitesh Sharma |
An evaluation from a Technologist perspective following the installation of a fixed-ring digital SPECT/CT system Elizabeth Bailey |
||||
Session sponsored by: |
Infection Control Knowledge and Training among Nuclear Medicine Technologists Peter Kench |
|||||
| 3:30pm | 4:00pm | AFTERNOON TEA | ||||
| 4:00pm |
5:30pm |
Oncology: Read with the Experts | Lung Imaging / Infection Imaging | National Imaging Facility Session (NIF) | TSIG Session: Theranostics and General NM | |
| Royal Theatre | Swan Room/Torrens Room | Murray Room | Bradman Theatre | |||
| How to PRIMARY Score James Buteau |
68Ga-DOTANOC PET/CT in Differentiating Sarcoid versus Tubercular Lymphadenopathy: Is there a role? Nishikant Damle |
Welcome Andrew Scott |
Nuclear Medicine Technologists in Theranostics International Consortium (NMTTIC) – ANZSNM, EANM-TC, SNMMI-TS, IAEA Karen Jones, Julie Bolin, Suzi McGavin, Kunthi Pathmaraj, Luisa Roldaopereira |
|||
| Interesting cases and Pearls, including PET in Immunotherapy: Gabrielle Cehic Rahul Solanki Natalia Kovaleva Sze Ting Lee |
FDG PET-CT Detection of Occult TAVI Endocarditis in Persistent Sepsis: A Regional Diagnostic Challenge Jennifer Walter |
Update on NIF activities and plans Andrew Scott |
A cornerstone to changing dialysis patient outcomes: A Case Study Lyndl Counsell |
|||
| Utilising 124I-PET imaging to determine the biodistribution of corticosterone-binding globulin during the treatment of life-threatening sepsis. Luke Darveniza |
NIF HMI Clinical Trials Theme Roslyn Francis, Karen Lindsay |
Practicing to Full Scope: Expanding Nuclear Medicine Scientist Medicine Administration for Service Sustainability. Maddison Carroll |
||||
| Ga-68 DOTATATE PET/CT in a 19-Year-Old Male With Left Optic Nerve Sheath Meningioma: Diagnostic Utility in Differentiating Inflammatory Perineuritis Winsome Chan |
NIF HMI Harmonisation Oncology Theme Roslyn Francis, Alison Nixon |
From Complaint to Resolution: Ensuring a Safe Workplace and Protecting the Public Alison Brown |
||||
| Pre Treatment Evaluation of Lung Malignancy with Quantitative VQ SPECT CT Chong Chew |
NIF HMI NeuroPET Theme Leigh Johnson |
|||||
| Quantitative VQ SPECT CT and Quantitative CT Assessment of Lobar Effects following Bronchoscopic Lung Volume Reduction with Endobronchial Valves. (EMPHYSISE sub study) Chong Chew |
NIF HMI Radiochemistry Theme Andrew Scott, Farrah El-Saafin |
|||||
| NIF Total Body PET Update Steven Meikle |
||||||
| NIF preclinical program Ingrid Burvenich |
||||||
| 7:00pm | 11:00pm | Awards Dinner | NCCC, Ballroom | ||||
Annual Scientific Meeting Day 3 |
||||||
| Start | End | Session / Details | ||||
| 8:30am |
10:00am |
Neurology: Read with the Experts |
Paediatric: Read with the Experts (Kidneys, Cancers and Curveballs) | Clinical Trials in Theranostics | Dosimetry / Biodistribution | |
| Royal Theatre | Swan Room/Torrens Room | Murray Room | Bradman Theatre | |||
| Geoff Schembri | Renal Cases Monica Rossleigh |
Research in Progress: The Tumorad Trial: A Phase 1/IIA Trial of a therapeutic alternative for metastatic solid cancers unresponsive to other therapies. Kim Taubman |
First in human feasibility, biodistribution, dosimetry, and safety assessment of low-dose Lutetium-177 labelled novel PSMA targeting peptide NTA-476 Aviral Singh |
|||
| Tahleesa Cuda | PET/CT Oncology Bruce Goodwin |
Navigating Complexities in Coordinating Radiopharmaceutical Trials Vicki Sproule |
Comparison of Published Methods for I-124 Pre-Therapy Dosimetry George Rouvalis |
|||
| Kim Taubman | Thyroid Cases Elizabeth Thomas |
Phase 3 study to assess safety and efficacy of 177Lu-girentuximab in advanced relapsed or recurrent ccRCC (LUTEON) Andrew Scott |
Influence of Patient Body Habitus on Effective Dose Estimation in Myocardial Perfusion Imaging: An Initial Monte Carlo Study Jason Tse |
|||
| Mixed Bag Karan Singh, Khoa Nguyen |
Estimated Extremity Dose to Clinical Research Coordinators Handling Blood Samples in Theranostics Clinical Trials Tiffany Briggs |
Feasibility, Biodistribution, and Dosimetry of the Novel PSMA-Binding Peptide NTA-476 labelled with Gallium-68 – a First-in-Human Application Aviral Singh |
||||
| Safety and Efficacy of Dose-Escalated ¹⁷⁷Lutetium PSMA Therapy in Metastatic Castrate-Resistant Prostate Cancer: A Dose Escalation Study. Dharmender Malik |
Impact of Number of Imaging Time Points on I-124 Pre-Therapy Dosimetry Estimates George Rouvalis |
|||||
| IPAX BrIGHT: Pivotal study of iodofalan with or without lomustine vs lomustine alone for the treatment of patients with radiographically confirmed recurrent glioblastoma at first recurrence Andrew Scott |
||||||
Session sponsored by: |
||||||
| 10:00am | 10:30am | MORNING TEA |
Sponsored by:
|
|||
| 10:30am | 12:00pm | Royal Theatre | ||||
| Plenary: Oncology | ||||||
| Where is the Digital Imaging Evolution taking us? – Dr Kathy Willowson | ||||||
| Alpha Radiopharmaceutical Therapy in Non-Prostate Malignancies – Prof Hossain Jadvar | ||||||
| Advances in Neuro-Oncology – Prof Hui Gan | ||||||
| 12:00pm | 12:30pm | Pioneer Lecture: The development and evolution of a mature nuclear medicine service in a regional metropolitan hospital – A/Prof Barry Elison | ||||
| 12:30pm | 1:15pm | ANZSNM AGM | ||||
| 1:15pm | 2:00pm | LUNCH |
Sponsored by:
|
|||
| Nursing Workshop | Murray Room |
Sponsored by:
|
|||||
| Regional/Rural Meet and Greet; Presentation | Fitzroy Room | ||||||
| 2:00pm |
3:30pm |
Infection / Inflammation Session | ANZSNM Quality and Technical Standards Committee Session | General PET/CT | Radiopharmaceutical Sciences | |
| Royal Theatre | Swan Room/Torrens Room | Murray Room | Bradman Theatre | |||
| FDG PET in Vasculitis and Polymyalgia Rheumatica: Clinical Utility and Diagnostic Performance Anthony Sammel |
Getting it right: surviving site validation for a clinical trial Ben Crouch, Jessica Fagan, Steven Harvey, Kimberly Nguyen, George McGill |
Audit of Blood Ketone Levels and Myocardial FDG Suppression in Cardiac FDG PET Imaging: A Prospective Audit Winsome Chan |
Development of an Automated Electroplating System for Solid Target Preparation in Alpha Emitter Production Mario Malinconico |
|||
| FDG PET in Vasculitis and Polymyalgia Rhematica: Reporting Pearls and Pitfalls Karan Singh |
AI-Assisted Segmentation and TNM Classification of PSMA PET/CT Lesions for Prostate Cancer Staging David Han |
Radiopharmaceuticals: Routine vs Revolutionary – A Public Hospital perspective Stuart McCluskey |
||||
| Beyond the Echo: Diagnostic utility of F18-FDG PET/CT in Cardiac Infections Varun Moorthy |
Radiomic Features from Baseline 18F‑FDG PET for Prediction of Treatment Response in Diffuse Large B‑Cell Lymphoma: A Pilot Study Dharmender Malik |
Innovative 68Ga and 89Zr production Utilizing Alceo and Synthera Platforms: A New Commercial Solution for Radiopharmaceutical Production Mario Malinconico |
||||
| Phase 3 study of 68Ga-PSMA-11 PET combined with MRI for the detection of prostate cancer (BiPASS) Andrew Nguyen |
Gallium-68 (Ga-68) Production Challenges and the Alternatives for Improved Theranostics Practice Franklin Eze |
|||||
Session sponsored by: |
Enhanced Production Of Co-55 Through Automated Electroplating And Purification Techniques Mario Malinconico |
|||||
| 3:30pm | 4:00pm | Closing Ceremony and Handover | Royal Theatre | ||||
Meeting brought to you by ANZSNM
Contact Info
If you have queries regarding the Australian and New Zealand Society of Nuclear Medicine (ANZSNM) 56th Annual Scientific Meeting, please contact the Meeting Office.
Think Business Events
Level 1, 4 Anderson Street
Port Melbourne VIC 3207
T: +61 (2) 8815 8180
anzsnm@thinkbusinessevents.com.au
www.thinkbusinessevents.com.au
Stay secure: To protect against fraud, please note that all official correspondence from the ANZSNM ASM will only be sent via a @thinkbusinessevents.com.au, or @ozaccom.com.au email address
Acknowledgement of country
The ANZSNM is committed to providing equitable and high-quality patient care, through the use of diagnostic and therapeutic nuclear medicine, striving to improve outcomes for all people living in Australia and New Zealand, irrespective of gender, sexuality, cultural background or ability. We acknowledge the Traditional Owners of the Country throughout Australia, recognise Aboriginal and Torres Strait Islander peoples continuing connection to land, waters, and culture, and we pay our respects to their Elders past, present and future. ANZSNM acknowledges Māori as Tangata Whenua and Te Tiriti o Waitangi partners in Aotearoa New Zealand, striving to achieve Pae Ora (healthy futures) for all. We recognise the knowledge systems, sciences, and practices of Aboriginal, Torres Strait Islander and Māori people, which have empowered generations to thrive.
Copyright © 2026 Think Business Events All rights reserved. | Website design by Designo Videre